United States Orthopedic Imaging Modalities and Orthopedic Surgical Navigation Systems Market to 2031 – Featuring Canon, FUJIFILM Holdings, General Electric and Johnson & Johnson Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “U.S. Orthopedic Imaging Modalities and Orthopedic Surgical Navigation Systems Market: Focus on Modality, Application, and End User – Analysis and Forecast, 2022-2031” report has been added to ResearchAndMarkets.com’s offering.

The U.S. orthopedic imaging modalities and U.S. orthopedic surgical navigation systems market is segmented into U.S. orthopedic imaging modalities market and U.S. orthopedic surgical navigation systems market.

The report highlights that the U.S. orthopedic imaging modalities market was valued at $2,697.8 million in 2022 and is expected to reach $3,989.9 million by the end of 2031.

The market is expected to grow at a CAGR of 4.44% during the forecast period 2022-2031. The market is driven by factors such as technological advancements in the imaging field, the increasing incidences of orthopedic diseases and bone injuries, and the growing demand for point of care (POC) ultrasound systems in orthopedic applications.

In addition to this, the report also highlights that the U.S. orthopedic surgical navigation systems market was valued at $262.9 million in 2022 and is expected to reach $460.9 million by the end of 2031.

The market is expected to grow at a CAGR of 6.43% during the forecast period 2022-2031. The market is driven by factors such as the increasing number of joint replacement surgery and the increasing preference for minimally invasive surgery.

Market Lifecycle Stage

The U.S. orthopedic imaging modalities market is in the developed phase. The rising incidence of orthopedic indications and the upsurge in technological advancements are some of the major opportunities in the U.S. orthopedic imaging modalities market. Furthermore, some of the current key trends in the market are the inclination toward magnetic resonance imaging (MRI) systems and the integration of artificial intelligence (AI) in imaging modalities.

On the other hand, the U.S. orthopedic surgical navigation systems market is in the developing phase. The increasing preference for minimally invasive surgeries (MIS) and rising numbers of joint replacement surgeries are some of the major opportunities in the U.S. orthopedic surgical navigation systems market.

Recent Developments in the U.S. Orthopedic Imaging Modalities and U.S. Orthopedic Surgical Navigation Systems Market

In February 2022, FUJIFILM Holdings Corporation launched the Sonosite LX ultrasound system.

In December 2021, DePuy Synthes, a subsidiary of Johnson & Johnson, acquired OrthoSpin Ltd. to advance its innovation in the Medtech space.

In November 2021, FUJIFILM Holdings Corporation launched Persona CS Mobile Fluoroscopy System expanding its C-arm portfolio.

In September 2021, GE Healthcare, a subsidiary of General Electric Company, entered into an agreement to acquire BK Medical, a company that deals in surgical visualization. Through the acquisition, GE added a real-time surgical visualization field to the company’s pre- and post-operative ultrasound capabilities.

In September 2021, Canon Inc. announced getting into a definitive agreement to acquire Redlen Technologies Inc. Through this acquisition, Canon Inc. aimed to expand and improve the medical business of the company.

Demand – Drivers and Limitations

U.S. Orthopedic Imaging Modalities Market

The following are the drivers for the U.S. orthopedic imaging modalities market:

Technological Advancements in Imaging

Increasing Incidences of Orthopedic Diseases and Bone Injuries

Growing Demand for POC Ultrasound Systems in Orthopedic

The market is expected to face some limitations as well due to the following challenges:

Health Risks and Healthcare Costs from Potentially Inappropriate High-Cost Imaging

Recall of Imaging Systems

U.S. Orthopedic Surgical Navigation Systems Market

The following are the drivers for the U.S. orthopedic surgical navigation systems market:

Increasing Number of Joint Replacement Surgeries

Increasing Preference for Minimally Invasive Procedures

The market is expected to face some limitations as well due to the following challenges:

High Cost of Robotic Navigation System

Companies Mentioned

Canon Inc.

FUJIFILM Holdings Corporation

General Electric Company

Johnson & Johnson

Konica Minolta, Inc.

Koninklijke Philips N.V.

Medtronic plc

OrthAlign, Inc.

Shimadzu Corporation

Siemens Healthineers AG

Smith & Nephew plc

SonoScape Medical Corp.

Stryker Corporation

United Imaging Healthcare Co., Ltd.

Zimmer Biomet Holdings, Inc.

Market Segmentation

U.S. Orthopedic Imaging Modalities Market

Segmentation 1: by Application

Hip

Knee

Spine

Other Extremities

The U.S. orthopedic imaging modalities devices market (by application) is expected to be dominated by the spine segment.

Segmentation 2: by Modality

X-Ray

Computed Tomography (CT) Scanners

Magnetic Resonance Imaging (MRI) Systems

Ultrasound Systems

The U.S. orthopedic imaging modalities devices market (by modality) is expected to be dominated by the X-Ray segment.

Segmentation 3: by End User

Hospitals

Ambulatory Surgery Centers

Others

The U.S. orthopedic imaging modalities devices market (by end user) is dominated by the hospitals segment.

U.S. Orthopedic Surgical Navigation Systems Market

Segmentation 1: by Application

Joints

Spine

The U.S. orthopedic surgical navigation systems market (by application) is expected to be dominated by the spine segment.

For more information about this report visit https://www.researchandmarkets.com/r/tee2hr-s-orthopedic?w=4

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.